Inotek Pharmaceuticals (United States)
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Inotek Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
32%
Total
Publications
258
Total Open
Publications
83
Total
Citations
19K
Open Access
Percentage
32%
Total
Publications
258
Total Open
Publications
83
Total
Citations
19K
Breakdown
Publisher Open
16%
Both
7%
Other Platform Open
10%
Closed
67%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
24
Hybrid 3%
2
No Guarantees 58%
36
Other Platform Open
Institution 56%
25
Other Internet 33%
15
Domain 24%
11
Public 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
University of Debrecen | Institution | 17 |
DOI | Other Internet | 15 |
PubMed Central | Domain | 11 |
Swiss School of Archaeology in Greece | Institution | 3 |
University of Michigan–Ann Arbor | Institution | 2 |
Figshare | Public | 2 |
University of Salford | Institution | 1 |
Universitat Politècnica de València | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |